• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

    0.6200 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 0.6000 (800)
    Ask (Size) 0.6360 (100)
    Prev. Close 0.6200
    Today's Range 0.6200 - 0.6200
    52wk Range 0.4800 - 2.430
    Shares Outstanding 22,225,846
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
    Via ACCESS Newswire
    News headline image
    Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via ACCESS Newswire

    Performance

    YTD
    -73.0%
    -73.0%
    1 Month
    -41.5%
    -41.5%
    3 Month
    -52.7%
    -52.7%
    6 Month
    -34.7%
    -34.7%
    1 Year
    -71.8%
    -71.8%

    More News

    Read More
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Which stocks are gapping on Monday? ↗
    Via Chartmill
    News headline image
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via ACCESS Newswire
    News headline image
    Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
    Via ACCESS Newswire
    News headline image
    Lexaria Bioscience Corp. Provides Strategic Update
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via ACCESS Newswire
    News headline image
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    News headline image
    Nasdaq Gains 100 Points; US Consumer Sentiment Falls ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Friday? ↗
    Via Chartmill
    News headline image
    Friday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot ↗
    Via Benzinga
    Topics Economy Stocks
    News headline image
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Via ACCESS Newswire
    News headline image
    Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    Why Are Lexaria Bioscience Shares Soaring 45% After Hours? ↗
    Via Benzinga
    News headline image
    Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
    Via ACCESS Newswire
    News headline image
    Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
    Via ACCESS Newswire
    News headline image
    GLP-1 "Arms Race" Broadens to Include Dozens of Companies
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Lexaria Bioscience Corp. - Common Stock publicly traded?
    Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
    What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
    Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
    The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
    What is the current price of Lexaria Bioscience Corp. - Common Stock?
    The current price of Lexaria Bioscience Corp. - Common Stock is 0.6200
    When was Lexaria Bioscience Corp. - Common Stock last traded?
    The last trade of Lexaria Bioscience Corp. - Common Stock was at 12/23/25 04:00 PM ET
    What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
    The market capitalization of Lexaria Bioscience Corp. - Common Stock is 13.78M
    How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
    Lexaria Bioscience Corp. - Common Stock has 14M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.